Extracorporeal removal of soluble tumor necrosis factor receptors for the treatment of advanced refractory solid tumors. The first cold atmospheric plasma phase I clinical trial for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results